Clinical Trials Sponsored by pSivida Corp.

Total 913 results

Green Cross Corporation

Completed

Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

Prevention of Influenza
Green Cross Corporation

Completed

Efficacy and Safety of Recombinant Factor VIII (GreenGene) in Patients With Hemophilia A

Hemophilia A
EyeQue Corp.
The Emmes Company, LLC

Not yet recruiting

EyeQue VisionCheck 510(k) Clinical Trial

Refractive Errors | Astigmatism
Ottawa Hospital Research Institute
ISBRG Corp

Recruiting

SpotLight-19 Research & Development Study

Screening

Canada
Angion Biomedica Corp
Nucleus Network Ltd

Not yet recruiting

Study to Evaluate the Pharmacokinetics of ANG-3777 in Hemodialysis Subjects

Hemodialysis

United States
Zaycor Healthcare Corp
BioScience Laboratories, Inc.

Not yet recruiting

Pilot Clinical Trial - Comparative Study of Two Material Concentration of OD-141309 (Odysseus-01)

Infectious Disease
Western University, Canada
Cosm Medical Corp.

Completed

Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation

Prolapse

Canada
Myant Medical Corp.
University of Waterloo

Completed

Validation of Smart Garments for Metabolic Rate Estimation

Healthy

Canada
Northwest Surgical Specialists, Vancouver
Stryker Corp.

Completed

Survivorship and Outcomes of Robot Assisted Medial Partial Knee Replacement

Unicompartmental Knee Arthroplasty

United States
Cellxpert Biotechnology Corp.
Medigen Biotechnology Corporation

Completed

Trial of PI-88 With Docetaxel in Advanced Non-Small-Cell Lung Cancer (NSCLC)

Carcinoma, Non-Small-Cell Lung

Australia
Steeve Provencher
Resverlogix Corp

Completed

Apabetalone for Pulmonary Arterial Hypertension: a Pilot Study (APPRoAcH-p)

Pulmonary Arterial Hypertension

Canada
Massachusetts General Hospital
Mitre Medical Corp.

Completed

Collection of Breath and Sweat to Identify Indicators of Hypoglycemia

Type 1 Diabetes Mellitus

United States
Green Cross Corporation

Completed

A Study to Assess Safety, Efficacy, Immunogenicity, PK of GC1118 With Combination Chemotherapy

Metastatic Colorectal Cancer | Solid Tumor

Korea, Republic of
Green Cross Corporation

Withdrawn

Study of Immune Globulin Intravenous (Human) GC5101F in Subjects With Primary Humoral Immunodeficiency

Primary Immune Deficiency Disorder
Green Cross Corporation

Unknown

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults

Whooping Cough | Tetanus | Diphtheria

Korea, Republic of
Green Cross Corporation

Completed

A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3114 in Healthy Adults

Influenza, Human

Korea, Republic of
Yale University
Cell Science Systems, Corp.

Completed

Irritable Bowel Syndrome and Food Sensitivity

Irritable Bowel Syndrome

United States
Green Cross Corporation

Unknown

Safety Study of GC1118 (Recombinant Human Anti-EGFR Antibody) in Patients With Advanced Solid Cancer

Neoplasm Metastasis | Gastric Cancer | Colorectal Cancer

Korea, Republic of
Green Cross Corporation

Completed

A Phase 2 Study of GC1102 (Recombinant Hepatitis B Immunoglobulin) in HBV-related Liver Transplant Recipients

Hepatitis B Infection

Korea, Republic of
Green Cross Corporation

Completed

Evaluate the Safety and Exploratory Efficacy of GC1119

Fabry Disease

Korea, Republic of
Green Cross Corporation

Unknown

Study of Idursulfase-beta (GC1111) in Hunter Syndrome

Mucopolysaccharidosis II
Green Cross Corporation

Completed

A Multicenter, Double-blind, Parallel Phase III Study

Influenza

Korea, Republic of
Green Cross Corporation

Completed

Study to Evalutate Long-term Immunity of Hantavax in High Risk Population of HFRS

Infection
Green Cross Corporation

Completed

Study for Hyalobarrier to Evaluate Anti-adhesive Effect and Safety Compared to Guardix-SG After Thyroidectomy

Thyroid Disease

Korea, Republic of
Green Cross Corporation

Completed

Safety and Pharmacokinetics Study of Healthy Male Adults When Repeatedly Administered Through Intravenous Injection

Hepatitis B

Korea, Republic of
Green Cross Corporation

Completed

To Evaluate the Safety of 'Shinbaro Capsule'in Patients With Osteoarthritis

Osteoarthritis

Korea, Republic of
Green Cross Corporation

Completed

Study of Combined Therapy of Aspirin and "IVIG-SN" in Kawasaki Disease

Kawasaki Disease

Korea, Republic of
Bernstein, Jonathan A., M.D.
Dyax Corp.

Unknown

Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema (ACE)

Angioedema

United States
Green Cross Corporation

Completed

Efficacy and Safety of Shinbaro Capsule

Osteoarthritis
Green Cross Corporation

Completed

A Study to Evaluate the Safety and Immunogenicity of an Inactivated Split-virion Influenza A(H1N1) Vaccine

Influenza Infection
University College Cork
Cork University Maternity Hospital

Completed

RCT: The Effect of Held Position During Kangaroo Care on Physiological Parameters of Premature Infants

Premature Birth | Very Low Birth Weight Infant | Extreme Prematurity | Extremely Low Birth Weight

Ireland
Fundacio Privada Mon Clinic Barcelona
Miracor Medical SA

Not yet recruiting

Effects of Pressure-controlled Intermittent Coronary Sinus Occlusion (PiCSO) Therapy on miRNAs Expression and Absolute Microvascular Resistance by Continuous Thermodilution in ST-segment Elevation Myocardial Infarction (STEMI) Patients: PiCSO-STEMI TRIAL (PiCSO-STEMI)

Anterior Myocardial Infarction
Taoyuan General Hospital
Medigen Vaccine Biologics Corp.

Recruiting

A Heterologous 3rd COVID-19 Vaccine of MVC-COV1901 to Evaluate Immunogenicity and Safety in Adults With ChAdOx1-nCov-19

COVID-19 Vaccine

Taiwan
SyneuRx International (Taiwan) Corp
Amarex Clinical Research

Recruiting

An Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults

Refractory Schizophrenia

United States
Nelum Corp
Apices Soluciones S.L.; Agenus Inc.

Active, not recruiting

Study to Evaluate the Safety and Efficacy of Treatment With NLM-001 and Standard Chemotherapy Plus Zalifrelimab in Patients With Advanced Pancreatic Cancer (NUMANTIA)

Pancreatic Ductal Adenocarcinoma

Spain
Anavex Life Sciences Corp.
Anavex Germany GmbH

Completed

ANAVEX2-73 Study in Parkinson's Disease Dementia

Parkinsons Disease With Dementia

Spain, Australia
TotipotentSC Scientific Product Pvt. Ltd.
Thermogenesis Corp.

Completed

Safety and Efficacy of Autologous Bone Marrow Mononuclear Cells in Patients With Severe Critical Limb Ischemia

Critical Limb Ischemia

India
Green Cross Corporation
Parexel

Completed

A Study to Access Safety, Tolerability, Pharmacokinetics(PK) and Pharmacodynamics(PD) of Orally Administered GCC-4401C in Healthy Volunteers

Healthy Volunteers

United States
Green Cross Corporation
Symyoo

Completed

GCPGC in Chemotherapy-induced Neutropenia

Chemotherapy Induced Neutropenia

Korea, Republic of
Archemix Corp.
St George's, University of London

Terminated

Effect of ARC1779 on Cerebral Microembolism in Patients Undergoing Carotid Endarterectomy

Carotid Stenosis | Intracranial Embolism | Cerebral Thromboembolism

United States, United Kingdom
Oles Honchar Dnipro National University
SynthezAI Corp.

Recruiting

Study of the Effect of the Auditory Stimulation on Stuttering Symptoms in Patients With a Deficit of Spectral Power in the EEG Beta Frequency Band (ZOV)

Stuttering, Adult | Stammering

Ukraine
Nova Mentis Life Science Corp
FourthWall Testing

Recruiting

Establishing a Diagnostic and Therapeutic Index in Autism Spectrum Disorder (ASD) and Fragile X Syndrome

Autism Spectrum Disorder | Fra(X) Syndrome

United States
Northwest Surgical Specialists, Vancouver
Stryker Surgical Corp

Active, not recruiting

Clinical and Economic Comparison of Robot Assisted Versus Manual Knee Replacement

Knee Arthroplasty

United States
Resverlogix Corp
PPD; ICON plc; Medidata Solutions

Completed

Effect of RVX000222 on Time to Major Adverse Cardiovascular Events in High-Risk T2DM Subjects With CAD (BETonMACE)

Coronary Artery Disease | Diabetes Mellitus, Type 2

Netherlands, Taiwan, Argentina, Israel, Poland, Russian Federation, Australia, Belgium, Serbia, Bulgaria, Hungary, Slovakia, Mexico, Croatia, Germany
University of British Columbia
Lexaria Bioscoence Corp

Unknown

Cannabinoid Supplementation on Vascular and Cognitive Function

Diet Modification

Canada
Yonsei University
Chong Kun Dang Pharmaceutical Corp.

Unknown

Assessment of Change in Atherosclerotic Plaque by Serial CCTA (ACROSS)

Coronary Artery Disease | Coronary Arteriosclerosis | Hydroxymethylglutaryl-CoA Reductase Inhibitors

Korea, Republic of
Dana-Farber Cancer Institute
Synta Pharmaceuticals Corp.

Terminated

STA-9090(Ganetespib) in Patients With Unresectable Stage III or Stage IV Melanoma

Melanoma

United States
Seoul National University Hospital
GC Biopharma Corp

Completed

Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor (MG4101)

Solid Tumors | Malignant Lymphomas

Korea, Republic of
Green Cross Corporation
Symyoo

Terminated

GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock

Septic Shock | Severe Sepsis

Korea, Republic of
Green Cross Corporation
Symyoo

Completed

To Evaluate the Safety, Tolerability, and Pharmacokinetics/Pharmacodynamics of Erythropoietin

Healthy Volunteer

Clinical Trials Sponsored by pSivida Corp.

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Poland

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations